Table 3.
The relationship between levels of the β1-AA, sST2 and the all-cause mortality in patients with ADHF by Chi-square analysis.
| All-cause mortality % (n) | chi-square value | df | P-value | ||
|---|---|---|---|---|---|
| High | Low | ||||
| β1-AA (N = 96) | 25% (24) | 15.63% (15) | 5.671 | 1 | 0.017 |
| sST2 (N = 96) | 26.04% (25) | 14.58% (14) | 6.028 | 1 | 0.014 |
| β1-AA+sST2 (N = 70) |
27.14% (19) | 12.85% (9) | 8.037 | 1 | 0.018 |
High: the level of β1-AA was above the mean in β1-AA line, the level of sST2 was above the median in sST2 line, the level of β1-AA and sST2 was both above their mean or median in β1-AA+ sST2 line.
Low: the level of β1-AA was below the mean in β1-AA line, the level of sST2 was below the median in sST2 line, the level of β1-AA and sST2 was both below their mean or median in β1-AA+ sST2 line.
Compared with the low value group, the all-cause mortality in the high value group was significantly increased, and P < 0.05.